Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY12.93 CNY
Change Today -0.62 / -4.58%
Volume 16.6M
300086 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

hainan honz pharmaceutical-a (300086) Snapshot

Open
CNY12.51
Previous Close
CNY13.55
Day High
CNY14.25
Day Low
CNY12.29
52 Week High
06/15/15 - CNY53.60
52 Week Low
12/22/14 - CNY12.28
Market Cap
3.9B
Average Volume 10 Days
13.9M
EPS TTM
CNY0.20
Shares Outstanding
300.0M
EX-Date
--
P/E TM
65.2x
Dividend
CNY0.10
Dividend Yield
--
Current Stock Chart for HAINAN HONZ PHARMACEUTICAL-A (300086)

Related News

No related news articles were found.

hainan honz pharmaceutical-a (300086) Related Businessweek News

No Related Businessweek News Found

hainan honz pharmaceutical-a (300086) Details

HaiNan Honz Pharmaceutical Co.,Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products with a focus on children health in China. It offers chemical and traditional Chinese medicines in the areas of antipyretic analgesics, cold, antibiotics, antianaphylaxis, digestive aids, and nutrition boosters. The company's chemical medicine products include Ribavirin granules to treat respiratory syncytial virus-related diseases; Cefaclor granules for the treatment of various kinds of infections by sensitive bacteria; Lacidophilin granules for diarrhea indigestion and enteritis; Ibuprofen granules to alleviate mild to moderate pain; Co.Paracetamol granules for the treatment of common cold or influenza in children; and Albumin Tannate and Barm powder used for the treatment of diarrhea caused by indigestion and enteritis. Its traditional Chinese medicines comprise Xiao'er fuxie powder to treat diarrhea and associated symptoms; Xiao'er Magan and Zhike Juhong granules to relieve coughs and reduce phlegm; Jian'erle granules for indigestion treatment; and Xiao'er Qingjie granules to bring down fever and relieve irritation, dry mouth, sore throats, and muscle aches. The company is headquartered in Guangzhou, China.

hainan honz pharmaceutical-a (300086) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hainan honz pharmaceutical-a (300086) Key Developments

Hainan Honz Pharmaceutical Co., Ltd. Proposes Interim Tax Included Cash Dividend

Hainan Honz Pharmaceutical Co., Ltd. proposed interim tax included cash dividend of CNY 1.00 per 10 shares.

Hainan Honz Pharmaceutical Co., Ltd. to Amend Articles of Association

Hainan Honz Pharmaceutical Co., Ltd. at its second extraordinary general meeting of 2015; to be held on September 11, 2015, is to consider an amendments to the company's articles of association.

Hainan Honz Pharmaceutical Co., Ltd. to Report First Half, 2015 Results on Aug 25, 2015

Hainan Honz Pharmaceutical Co., Ltd. announced that they will report first half, 2015 results on Aug 25, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300086:CH CNY12.93 CNY -0.62

300086 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Pediatric Pharmaceuticals Inc $0.04 USD 0.00
View Industry Companies
 

Industry Analysis

300086

Industry Average

Valuation 300086 Industry Range
Price/Earnings 66.4x
Price/Sales 8.9x
Price/Book 1.9x
Price/Cash Flow 68.3x
TEV/Sales 9.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAINAN HONZ PHARMACEUTICAL-A, please visit www.honz.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.